Gene: CCDC110
Official Full Name: coiled-coil domain containing 110provided by HGNC
Gene Summary: Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21057 | CCDC110 Knockout cell line (HCT 116) | Human | CCDC110 | 1:2~1:4 | Negative | Online Inquiry |
KO21058 | CCDC110 Knockout cell line (HEK293) | Human | CCDC110 | 1:3~1:6 | Negative | Online Inquiry |
CCDC110 Gene Knockout Cell Lines represent a pivotal resource for researchers seeking to unravel the complex roles of the CCDC110 gene in cellular mechanisms and biological processes. These engineered cell lines have undergone precise gene editing to knock out the expression of the CCDC110 gene, enabling scientists to study its functions and implications in various cellular contexts, such as cell growth, proliferation, and response to stimuli.
The key function of these knockout cell lines lies in their ability to facilitate functional genomics studies, allowing researchers to observe phenotypic changes that arise from the absence of CCDC110. By analyzing these alterations, scientists can gain insights into the gene's contributions to key pathways and disease states, thus enhancing understanding of its biological importance. The knockout mechanism, typically achieved through CRISPR-Cas9 technology or similar genome editing techniques, ensures high specificity and efficiency, reducing off-target effects commonly associated with traditional gene disruption methods.
From a scientific standpoint, CCDC110 Gene Knockout Cell Lines provide essential tools for both basic and applied research. They are instrumental in investigating the roles of CCDC110 in pathological conditions, such as cancer, where understanding gene function can lead to the development of novel therapeutic strategies. Moreover, these cell lines are valuable in drug discovery and toxicology assessments, serving as a reliable model to evaluate the impact of chemical compounds on a specific genetic backdrop.
What sets our CCDC110 Gene Knockout Cell Lines apart is their rigorous validation, ensuring high reproducibility and consistent results across experiments. Coupled with comprehensive user support and detailed protocols, these cell lines provide researchers with the confidence needed to explore new avenues of investigation.
Ultimately, leveraging our extensive expertise in cellular biology and genetic engineering, we deliver not just a product, but a commitment to advancing research and clinical applications. Employing these knockout cell lines empowers scientists and clinicians alike to accelerate their discoveries and contribute to the evolving landscape of biomedical science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.